Human BDNF / Abrineurin Protein (E. coli), premium grade

  • GMP version GMP-BDFH15 is now available for seamless transition.
ユーザーレビュー
製品番号/仕様
価格
数量
Premium grade lyophilized
BDF-H5116-20ug
$250.00
BDF-H5116-50ug
$545.00
BDF-H5116-1mg (200ug X 5)
$4965.00
GMP lyophilized
GMP-BDFH15-50ug
$650.00
GMP-BDFH15-500ug (50ug X 10)
$4000.00
GMP-BDFH15-1mg (50ug X 20)
$5800.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Features and Advantages

    1. Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
    2. Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
    3. Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
    4. Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
    5. Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
  • Synonyms

    BDNF, ANON2, BULN2, Abrineurin

  • Source

    Human BDNF Protein (E. coli), premium grade (BDF-H5116) is expressed from E. coli cells. It contains AA His 129 - Arg 247 (Accession # P23560-1).

    Predicted N-terminus: Met

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
    GMP-BDFH15 is the GMP version of this BDF-H5116. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stage to later clinical phases.

    Request for sequence
  • Molecular Characterization

    BDNF Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries no "tag".

    The protein has a calculated MW of 13.6 kDa. The protein migrates as 15 kDa±3 kDa under reducing (R) condition, and 13 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE).

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.02 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 0.1% TFA, pH2.2 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process
  • Quality Description

    ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
    ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    BDNF SDS-PAGE

    Human BDNF Protein (E. coli), premium grade on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-CELL BASE

     BDNF CELL

    Human BDNF Protein (E. coli), premium grade (Cat. No. BDF-H5116) induced Human TrkB(Luc) HEK293 Reporter Cell-2. The EC50 for this effect is 6.094 μg/mL (Routinely tested).

    Protocol
  • Application Data

     BDNF APPLICATION DATA

    Human GDNF Protein (E. coli), premium grade (Cat. No. GDF-H5118) combined with Human BDNF Protein (E. coli), premium grade (Cat. No. BDF-H5116) could efficiently induce iPSC differentiation to dopaminergic (DA) neurons, with high expression of DA markers (TH-1, MAP2) in immunofluorescence and FACS.

  •  BDNF APPLICATION DATA

    GMP Human BDNF Protein (E. coli) (Cat. No. GMP-BDFH15) could induce iPSC-derived dopaminergic neurons (DAN) differentiation, with high expression of DAN markers (TH, MAP2, and FOXA2) by FACS. This product exhibited similar performance in marker expression compared to Human BDNF Protein (E. coli), premium grade (Cat. No. BDF-H5116).

ユーザーレビュー
コメントを投稿

バックグランド

Brain-derived neurotrophic factor (BDNF) along with nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) are members of the neurotrophin family of trophic factors. The neurotrophins play essential roles in the development, survival, and function of a wide range of neurons in both the peripheral and central nervous systems. The neurotrophins interact with two cell surface receptors, the low affinity P75 receptor and the Trk family of high affinity tyrosine kinase receptors. NGF preferentially binds TrkA, BDNF and NT4/5 bind TrkB, and NT-3 binds TrkC (and TrkA to a lesser extent).

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Brain-derived neurotrophic factor

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    8 詳細

  • 最新の開発ステージ:

    Phase 3 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8